Numeco Obtains Product Approval for Botulinum Toxin 'Newlux' in Moldova
"Continued Expansion into Overseas Markets, Including Europe"
Numeco, a subsidiary of the biopharmaceutical company Medytox, announced on October 20 that it has obtained product approval for its botulinum toxin preparation 'Newlux' from the Medicines and Medical Devices Agency of Moldova.
Moldova is experiencing rapid growth in its medical tourism market, supported by excellent medical infrastructure and competitive pricing. According to the Moldovan Investment Agency, the medical tourism market reached approximately 64.4 million dollars (about 9.22 billion KRW) last year, more than 2.5 times the size in 2020. In particular, cosmetic procedures are gaining significant popularity, and the botulinum toxin market is also expected to see strong growth.
Previously, Medytox launched its botulinum toxin product 'Meditoxin' (export name: Neuronox) and its hyaluronic acid filler 'Neuramis' in the Moldovan market. The newly approved 'Newlux' boasts superior product quality and can be mass-produced, so it is expected to quickly establish itself in the market and drive further growth.
A Numeco representative stated, "We will actively leverage our long-established local network to ensure the successful market entry of 'Newlux,' which offers differentiated product quality," adding, "We will continue to expand into overseas markets, including Europe, to further strengthen our position as a global toxin brand."
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Meanwhile, 'Newlux,' which has entered markets in Asia, Europe, and South America, is characterized by enhanced production yield and quality through state-of-the-art processes. In addition, animal-derived ingredients are excluded from the raw material production process, eliminating the risk of allergic reactions caused by animal antigens. The chemical treatment process has also been minimized to reduce the denaturation of toxin proteins.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
